UNSPSC 85819317: Transfusion of embryonic stem cells into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of embryonic stem cells into peripheral vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30233AZ

UNSPSC 85819317 Transfusion of embryonic stem cells into peripheral vein, percutaneous approach is a Commodity code that shows minimal alignment with current state and local procurement activity. The code's nominal scope—a specific clinical procedure involving embryonic stem cell infusion—does not match the recent opportunities posted under this classification. State and local bodies are not soliciting embryonic stem cell transfusion services; instead, the opportunities tagged to this code address occupational medical surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, specialty surgical carve-outs, and emergency youth detention medical care. These services fall outside the code's stated scope and suggest either miscoding in the state and local procurement systems or administrative classification that does not reflect actual procurement intent.

The geographic spread of recent activity spans Arizona, California, Washington, Florida, and Texas, but the opportunities themselves bear no meaningful connection to the Commodity code's intended use. The City of Phoenix Retirement Office issued an RFP for independent medical evaluation services (due October 16, 2026); the City of Long Beach solicited surgical benefit carve-out program management (due October 7, 2026); Washington State Department of Transportation requested occupational medical surveillance services (due October 9, 2026); Harris County Juvenile Probation Department issued an RFI for youth detention medical services (due September 25, 2026); Collier County Board of County Commissioners requested pharmacy benefit management (due April 9, 2026, historical posting); and Santa Clara County Health System established a qualified vendor pool for temporary ancillary health professional staffing (due October 7, 2026). None of these solicitations involves embryonic stem cell therapy or the procedure specified in the code. The code appears dormant for state and local procurement purposes, or state procurement systems are applying it inconsistently to medical services outside its defined scope.